This clinical presentation is then compared with the recently described phenotype arising from recessively acting CHT mutations, consisting of a spectrum of congenital myasthenic syndrome (CMS) disorders, associated with biallelic SLC5A7 mutations. Here, SLC5A7 is linked to Congenital myasthenic syndromes.